Yield Spike Just Made RBI's Job Selling Indian Debt Much Harder
(Bloomberg) -- The surge in Indian bond yields to an 18-month high is having a side effect: the nation's central bank -- the government's debt manager -- is finding it harder to clear auctions.
The government couldn't sell 73 percent of the 150 billion rupees ($2.4 billion) of debt offered Dec. 29, and last week a fifth of 180 billion rupees of bonds remained unsold. The poor demand highlights the challenge the market faces in soaking up new issuance in the coming months, according to IDFC Asset Management Ltd. and Standard Chartered Plc.
“The virtual breakdown in market risk appetite, especially since December, doesn't augur well for absorption of future bond supplies,” said Suyash Choudhary, Mumbai-based head of fixed income at IDFC Asset, which managed 714 billion rupees at the end of December.
The government will sell 930 billion rupees of bonds in the March quarter, 500 billion rupees more than initially planned. On top of this, states are due to borrow as much as 1.4 trillion rupees, up 17 percent from a year ago.
Yield on the 6.79 percent sovereign debt due 2027, the most-traded paper, climbed 86 basis points in the five months ended December.
“RBI is probably not willing to provide a very high yield,” said Gopikrishnan MS, head of foreign exchange, rates and credit trading for South Asia at Standard Chartered. “At an absolute level of 7.30%, it is just about demand and supply,” he said, referring to the newly issued 10-year bond yield.
To contact the reporter on this story: Subhadip Sircar in Mumbai at ssircar3@bloomberg.net.
To contact the editors responsible for this story: Tan Hwee Ann at hatan@bloomberg.net, Ravil Shirodkar
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.